Deciphering complex protein interaction kinetics using Interaction Map

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 74-79

  Altschuh, Danièle ^a   Björkelund, Hanna ^b,c   Strandgård, John ^b   Choulier, Laurence ^a   Malmqvist, Magnus ^b,c,d   Andersson, Karl ^b,c,d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Ridgeview Instruments AB   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Ridgeview Diagnostics AB   (Sweden)

Author keywords

Heterogeneity; Kinetics; LigandTracer; Real time analysis; SPR

Indexed keywords

ARTICLE; BINDING AFFINITY; DISSOCIATION CONSTANT; KINETICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGRESSION ANALYSIS; SURFACE PLASMON RESONANCE;

COMPUTER SIMULATION; KINETICS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SURFACE PLASMON RESONANCE;

EID: 84868358922     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.008     Document Type: Article

References (19)

1. Yarden Y., Shilo B.Z. SnapShot: EGFR signaling pathway. Cell 2007, 131:1018.
2. Ozcan F., Klein P., Lemmon M.A., Lax I., Schlessinger J. On the nature of low- and high-affinity EGF receptors on living cells. Proc. Natl. Acad. Sci. USA 2006, 103:5735-5740.
3. Bjorkelund H., Gedda L., Barta P., Malmqvist M., Andersson K. Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with (1)(2)(5)I-EGF. PLoS One 2011, 6:e24739.
4. Mayawala K., Vlachos D.G., Edwards J.S. Heterogeneities in EGF receptor density at the cell surface can lead to concave up scatchard plot of EGF binding. FEBS Lett. 2005, 579:3043-3047.
5. Citri A., Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 2006, 7:505-516.
6. Gorshkova, Svitel J., Razjouyan F., Schuck P. Bayesian analysis of heterogeneity in the distribution of binding properties of immobilized surface sites. Langmuir 2008, 24:11577-11586.
7. Svitel J., Balbo A., Mariuzza R.A., Gonzales N.R., Schuck P. Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria. Biophys. J. 2003, 84:4062-4077.
8. Svitel J., Boukari H., Van Ryk D., Willson R.C., Schuck P. Probing the functional heterogeneity of surface binding sites by analysis of experimental binding traces and the effect of mass transport limitation. Biophys. J. 2007, 92:1742-1758.
9. Chen Z., Earl P., Americo J., Damon I., Smith S.K., Yu F., Sebrell A., Emerson S., Cohen G., Eisenberg R.J., Gorshkova I., Schuck P., Satterfield W., Moss B., Purcell R. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. J. Virol. 2007, 81:8989-8995.
10. Schmeisser H., Gorshkova I., Brown P.H., Kontsek P., Schuck P., Zoon K.C. Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2. Biochemistry 2007, 46:14638-14649.
11. Vorup-Jensen T., Carman C.V., Shimaoka M., Schuck P., Svitel J., Springer T.A. Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2. Proc. Natl. Acad. Sci. USA 2005, 102:1614-1619.
12. Barta P., Malmberg J., Melicharova L., Strandgard J., Orlova A., Tolmachev V., Laznicek M., Andersson K. Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line. Int. J. Oncol. 2012, 40:1677-1682.
13. J. Nilvebrant, G. Kuku, H. Björkelund, M. Nestor, Selection and in vitro characterization of human CD44v6-binding antibody fragments, Biotechnol. Appl. Biochem. (2012). http://dx.doi.org/10.1002/bab.1033.
14. Chatellier J., Van Regenmortel M.H., Vernet T., Altschuh D. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab. J. Mol. Biol. 1996, 264:1-6.
15. Choulier L., Laune D., Orfanoudakis G., Wlad H., Janson J., Granier C., Altschuh D. Delineation of a linear epitope by multiple peptide synthesis and phage display. J. Immunol. Methods 2001, 249:253-264.
16. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962, 194:495-496.
17. Bjorke H., Andersson K. Automated, high-resolution cellular retention and uptake studies in vitro. Appl. Radiat. Isot. 2006, 64:901-905.
18. Onell A., Andersson K. Kinetic determinations of molecular interactions using Biacore-minimum data requirements for efficient experimental design. J. Mol. Recognit. 2005, 18:307-317.
19. M. Malmqvist, K. Andersson, L. Lebel, H. Björkelund, L. Gedda, Method for diagnosis of individuals or animals, Patent application no. SE1200341-4, 2012.